Picture of Epigenomics AG logo

ECX — Epigenomics AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Epigenomics Q3 Net Loss At EUR -3.0 Mln

Nov 7 (Reuters) - EPIGENOMICS AG  ECXn.DE :
    * ANNOUNCES 2018 THIRD QUARTER AND NINE MONTHS FINANCIAL
RESULTS
    * EBITDA IN Q3 2018 WAS AT EUR -2.6 MILLION (Q3 2017: EUR
-2.0
MILLION)
    * NET LOSS AMOUNTED TO EUR -3.0 MILLION IN Q3 2018 COMPARED
TO EUR
-1.1 MILLION IN Q3 2017
    * TOTAL Q3 2018 REVENUE INCREASED TO EUR 0.5 MILLION (Q3
2017: EUR
0.3 MILLION)
    * ADJUSTED. EBITDA (EXCLUDING SHARE-BASED PAYMENT EXPENSES)
IS NOW
SEEN TO IMPROVE WITHIN RANGE EUR -11.0 MILLION AND EUR -13.0
MILLION

Source text for Eikon:  ID:nEQc5BxXya 
Further company coverage:  ECXn.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Epigenomics AG

See all news